SCN Corporate Connect Partners with The U-Group LLC to create a “Silicon Valley Hub” for NASDAQ’s Sponsored SCN Interviews
December 08, 2017 09:15 ET | Small Cap Nation
NEW YORK, NY, Dec. 08, 2017 (GLOBE NEWSWIRE) -- SCN Corporate Connect™, headquartered in New York and The U-Group LLC, headquartered in Silicon Valley, announced today a broad “Media-Based”...
Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company
October 17, 2017 08:00 ET | Neothetics, Inc.
SAN DIEGO, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) and Evofem Biosciences, Inc. today announced they have entered into a definitive agreement under which privately-held...
Neothetics Provides Business Update and Reports Second Quarter 2017 Financial Results
August 10, 2017 08:00 ET | Neothetics, Inc.
SAN DIEGO, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) provided a business update and reported financial results for the second quarter 2017. In July 2017, Neothetics announced...
Neothetics Announces Review of Strategic Alternatives
July 10, 2017 17:45 ET | Neothetics, Inc.
SAN DIEGO, July 10, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) announced today that its Board of Directors has unanimously approved plans to initiate a process to explore and review a...
Neothetics Announces Top-Line Results for Phase 2 Proof-of-Concept Study of LIPO-202 for the Reduction of Submental Subcutaneous Fat
June 26, 2017 08:00 ET | Neothetics, Inc.
SAN DIEGO, June 26, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced...
Neothetics Provides Business Update and Reports First Quarter 2017 Financial Results
May 11, 2017 08:00 ET | Neothetics, Inc.
SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today provided a...
Neothetics to Provide a Business Update and Release First Quarter 2017 Financial Results Thursday, May 11th, 2017
May 04, 2017 08:00 ET | Neothetics, Inc.
SAN DIEGO, May 04, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, announced today...
Neothetics Announces Issuance by USPTO of Eighth Patent Directed to LIPO-202 Lead Clinical Asset
April 05, 2017 08:00 ET | Neothetics, Inc.
SAN DIEGO, April 05, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today announced the...
Neothetics to Present at the 16th Annual Needham Healthcare Conference
March 29, 2017 08:00 ET | Neothetics, Inc.
SAN DIEGO, March 29, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that Susan A. Knudson, Neothetics’ Chief Financial Officer, will present at the 16th Annual Needham...
Neothetics Provides Business Update and Reports Fourth Quarter 2016 Financial Results
March 23, 2017 08:00 ET | Neothetics, Inc.
SAN DIEGO, March 23, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided a business update and reported financial results for the fourth quarter 2016. “We are encouraged by our...